Covidien Ltd has reported to the Associated Press that it plans to purchase
VNUS Medical Technologies for $440 million which Covidien believes will be
completed by the end of June. The varicose vein and venous disease industry
is said to be dramatically increasing as minimally invasive techniques and
procedures become more innovative, effective and cost efficient.
Forbes reported on the purchase saying, "San Jose, Calif.-based VNUS makes
products that treat varicose veins and venous reflux disease, a circulatory
condition that causes blood to pool in the veins of the leg. That can cause
swollen veins and discolored skin. Covidien said it is expanding its
vascular business by buying VNUS, and it will make VNUS part of its vascular
product line."
Similarly, VNUS is considered to be one of the most reputable firms in the
industry of varicose vein removal. As the industry begins to spread and
grow, many advocates for prevention hope that awareness about the diseases
and treatments will also boost.
